IDEXX LABORATORIES INC /DE Cost of Goods Sold (Deprecated 2018-01-31)
IDEXX LABORATORIES INC /DE (IDXX) reported Cost of Goods Sold (Deprecated 2018-01-31) of $127.27 million for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-08-01
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-06-30 was $127.27M, a 15.35% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $118.25M, a 14.77% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $123.24M, a 15.87% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $109.85M, a 5.72% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $446.45M, a 7.11% increase from fiscal 2016.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $416.81M, a 15.71% increase from fiscal 2015.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $360.21M, a 7.51% increase from fiscal 2014.
- IDEXX LABORATORIES INC /DE cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $335.05M, a 5.13% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-06-30 | $127.27M 10-Q · filed 2018-08-01 | $245.52M 10-Q · filed 2018-08-01 | $368.76M derived: sum of 3 quarters · filed 2018-08-01 | $478.61M derived: sum of 4 quarters · filed 2018-08-01 |
| 2018-03-31 | $118.25M 10-Q · filed 2018-05-04 | $241.49M derived: sum of 2 quarters · filed 2018-05-04 | $351.34M derived: sum of 3 quarters · filed 2018-05-04 | $461.67M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-12-31 | $123.24M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $233.09M derived: sum of 2 quarters · filed 2018-02-16 | $343.42M derived: sum of 3 quarters · filed 2018-08-01 | $446.45M 10-K · filed 2018-02-16 |
| 2017-09-30 | $109.85M 10-Q · filed 2017-10-31 | $220.18M derived: sum of 2 quarters · filed 2018-08-01 | $323.20M 10-Q · filed 2017-10-31 | $429.56M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-06-30 | $110.33M 10-Q · filed 2018-08-01 | $213.36M 10-Q · filed 2018-08-01 | $319.72M derived: sum of 3 quarters · filed 2018-08-01 | $423.63M derived: sum of 4 quarters · filed 2018-08-01 |
| 2017-03-31 | $103.03M 10-Q · filed 2018-05-04 | $209.39M derived: sum of 2 quarters · filed 2018-05-04 | $313.30M derived: sum of 3 quarters · filed 2018-05-04 | $422.21M derived: sum of 4 quarters · filed 2018-05-04 |
| 2016-12-31 | $106.36M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $210.27M derived: sum of 2 quarters · filed 2018-02-16 | $319.18M derived: sum of 3 quarters · filed 2018-02-16 | $416.81M 10-K · filed 2018-02-16 |
| 2016-09-30 | $103.91M 10-Q · filed 2017-10-31 | $212.82M derived: sum of 2 quarters · filed 2017-10-31 | $310.45M 10-Q · filed 2017-10-31 | $403.90M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $108.91M 10-Q · filed 2017-08-01 | $206.54M 10-Q · filed 2017-08-01 | $299.99M derived: sum of 3 quarters · filed 2018-02-16 | $392.18M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $97.63M 10-Q · filed 2017-04-28 | $191.08M derived: sum of 2 quarters · filed 2018-02-16 | $283.27M derived: sum of 3 quarters · filed 2018-02-16 | $374.47M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $93.45M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $185.63M derived: sum of 2 quarters · filed 2018-02-16 | $276.84M derived: sum of 3 quarters · filed 2018-02-16 | $360.21M 10-K · filed 2018-02-16 |
| 2015-09-30 | $92.19M 10-Q · filed 2016-11-01 | $183.39M derived: sum of 2 quarters · filed 2016-11-01 | $266.76M 10-Q · filed 2016-11-01 | $352.02M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $91.20M 10-Q · filed 2016-08-02 | $174.57M 10-Q · filed 2016-08-02 | $259.84M derived: sum of 3 quarters · filed 2017-02-17 | $344.62M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $83.37M 10-Q · filed 2016-04-29 | $168.63M derived: sum of 2 quarters · filed 2017-02-17 | $253.42M derived: sum of 3 quarters · filed 2017-02-17 | $340.37M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $85.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $170.05M derived: sum of 2 quarters · filed 2017-02-17 | $257.00M derived: sum of 3 quarters · filed 2017-02-17 | $335.05M 10-K · filed 2017-02-17 |
| 2014-09-30 | $84.78M 10-Q · filed 2015-10-28 | $171.74M derived: sum of 2 quarters · filed 2015-10-28 | $249.78M 10-Q · filed 2015-10-28 | $337.95M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $86.96M 10-Q · filed 2015-07-30 | $165.00M 10-Q · filed 2015-07-30 | $253.17M derived: sum of 3 quarters · filed 2016-02-17 | $329.69M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $78.04M 10-Q · filed 2015-04-28 | $166.21M derived: sum of 2 quarters · filed 2016-02-17 | $242.73M derived: sum of 3 quarters · filed 2016-02-17 | $322.58M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $88.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $164.69M derived: sum of 2 quarters · filed 2016-02-17 | $244.53M derived: sum of 3 quarters · filed 2016-02-17 | $318.69M 10-K · filed 2016-02-17 |
| 2013-09-30 | $76.52M 10-Q · filed 2014-10-24 | $156.36M derived: sum of 2 quarters · filed 2014-10-24 | $230.51M 10-Q · filed 2014-10-24 | $310.00M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $79.84M 10-Q · filed 2014-07-25 | $153.99M 10-Q · filed 2014-07-25 | $233.48M derived: sum of 3 quarters · filed 2015-02-17 | $306.22M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $74.15M 10-Q · filed 2014-04-25 | $153.64M derived: sum of 2 quarters · filed 2015-02-17 | $226.38M derived: sum of 3 quarters · filed 2015-02-17 | $304.85M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $79.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $152.23M derived: sum of 2 quarters · filed 2015-02-17 | $230.70M derived: sum of 3 quarters · filed 2015-02-17 | $305.91M 10-K · filed 2015-02-17 |
| 2012-09-30 | $72.74M 10-Q · filed 2013-10-22 | $151.21M derived: sum of 2 quarters · filed 2013-10-22 | $226.42M 10-Q · filed 2013-10-22 | $308.22M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $78.47M 10-Q · filed 2013-07-23 | $153.68M 10-Q · filed 2013-07-23 | $235.48M derived: sum of 3 quarters · filed 2014-02-18 | $312.31M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $75.21M 10-Q · filed 2013-04-23 | $157.01M derived: sum of 2 quarters · filed 2014-02-18 | $233.84M derived: sum of 3 quarters · filed 2014-02-18 | $311.30M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $81.80M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $158.63M derived: sum of 2 quarters · filed 2014-02-18 | $236.09M derived: sum of 3 quarters · filed 2014-02-18 | $309.80M 10-K · filed 2014-02-18 |
| 2011-09-30 | $76.83M 10-Q · filed 2012-10-19 | $154.29M derived: sum of 2 quarters · filed 2012-10-19 | $227.99M 10-Q · filed 2012-10-19 | $306.16M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $77.46M 10-Q · filed 2012-07-20 | $151.16M 10-Q · filed 2012-07-20 | $229.32M derived: sum of 3 quarters · filed 2013-02-19 | $296.40M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $73.70M 10-Q · filed 2012-04-20 | $151.87M derived: sum of 2 quarters · filed 2013-02-19 | $218.94M derived: sum of 3 quarters · filed 2013-02-19 | $291.01M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $78.16M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $145.24M derived: sum of 2 quarters · filed 2013-02-19 | $217.30M derived: sum of 3 quarters · filed 2013-02-19 | $285.94M 10-K · filed 2013-02-19 |
| 2010-09-30 | $67.08M 10-Q · filed 2011-10-21 | $139.14M derived: sum of 2 quarters · filed 2011-10-21 | $207.77M 10-Q · filed 2011-10-21 | $286.70M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $72.06M 10-Q · filed 2011-07-22 | $140.70M 10-Q · filed 2011-07-22 | $219.63M derived: sum of 3 quarters · filed 2012-02-17 | $291.17M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $68.63M 10-Q · filed 2011-04-21 | $147.56M derived: sum of 2 quarters · filed 2012-02-17 | $219.11M derived: sum of 3 quarters · filed 2012-02-17 | $290.41M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $78.93M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $150.47M derived: sum of 2 quarters · filed 2012-02-17 | $221.78M derived: sum of 3 quarters · filed 2012-02-17 | $281.04M 10-K · filed 2012-02-17 |
| 2009-09-30 | $71.54M 10-Q · filed 2010-10-22 | $142.85M derived: sum of 2 quarters · filed 2010-10-22 | $202.11M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $71.30M 10-Q · filed 2010-07-23 | $130.57M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $270.16M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |